Ducentis

Dualyx

This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.

Clinical-stage biotech

This company develops immunomodulatory recombinant protein therapies to treat autoimmune and chronic inflammatory diseases for patients with conditions such as chronic inflammatory demyelinating polyneuropathy.

Protuoso Biosciences

This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Delinia

This biotechnology firm develops protein therapeutics that rebalance the immune system to treat patients suffering from serious and life-threatening autoimmune diseases.

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Bright Peak Therapeutics

This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.